← Back to Search

Neurotoxin

Botox for Hypertrophic Scar

Phase 2
Waitlist Available
Research Sponsored by Roy G. Geronemus, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 6 months after treatment
Awards & highlights

Study Summary

This is a prospective, open label, single center, self-controlled clinical study to demonstrate the safety and efficacy of intradermal botulinum toxin in treating hypertrophic scarring.

Eligible Conditions
  • Hypertrophic Scar

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6 months after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 6 months after treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement of hypertrophic scars based on the Subject and Observer Scar Assessment Scale

Side effects data

From 2010 Phase 4 trial • 33 Patients • NCT00178646
8%
Foot pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
Low Volume, High Dose
High Volume, High Dose
Low Volume, Low Dose

Trial Design

1Treatment groups
Experimental Treatment
Group I: BotoxExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Botulinum toxin type A
FDA approved

Find a Location

Who is running the clinical trial?

Roy G. Geronemus, M.D.Lead Sponsor
AllerganIndustry Sponsor
781 Previous Clinical Trials
276,549 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Connecticut
How old are they?
65+
What site did they apply to?
Laser & Skin Surgery Center of New York
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Treatment of Hypertrophic Scars With Intradermal Botox
Roy G. Geronemus, M.D. 2018. "Treatment of Hypertrophic Scars With Intradermal Botox". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03631368.
All > Scar
~3 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top